Dr Britany Clarke

Industry Partnerships and Commercialisation Officer, Faculty of Medicine

Dr Britany Clarke is an Industry Partnership and Commercialisation Officer in the Faculty of Medicine at Imperial College London.

Britany’s work covers novelty and inventiveness assessment, intellectual property (IP) management, IP commercialisation in the form of exploiting data packages, out-licensing or spin-out formation. Britany manages an IP portfolio consisting of diagnostics, platform technologies and novel therapeutics. Additionally, in unison with Imperial academics and industry partners, Britany has devised IP strategies on successful, high-value and impactful translational funding grants.

Britany has a PhD in antimicrobial peptide libraries, phage display and microbial biotechnology from University of Nottingham, UK. Britany has also gained a Postgraduate Certificate in Education (PGCE) in Science and Biotechnology BSci additionally from the University of Nottingham.

Britany's portfolio

A real-time fluorescence probe for Heme Oxygenase activity

A real-time fluorescence probe for Heme Oxygenase activity

Novel heme oxygenase 1 (HO-1) probe compositions, and methods covering easy-to-use and rapid readouts of cell protection in cardiovascular diseases, hemorrhage and red cell disorders. Find out more

Functionalised biopolymer materials for extracellular vesicle isolation and engineering

Functionalised biopolymer materials for extracellular vesicle isolation and engineering

Methods for use in extracellular vesicle (EV), including exosomes, isolation and engineering applications broadly encompassing EV manufacturing, therapeutic, medical and diagnostics uses. Find out more

High-resolution transcription start site mapping using nanogram-levels of total RNA immunoprecipitation (SLIC-CAGE)

High-resolution transcription start site mapping using nanogram-levels of total RNA immunoprecipitation (SLIC-CAGE)

A novel development of the cap-trapper CAGE protocol which can generate complex high-quality libraries for as little as 5-10 nanograms of cellular RNA. Find out more

Sign up for updates

Sign up for monthly technology alerts via email, and find other ways to connect with us.

Loading...